2018 Archived Press Releases

2018 Archived Press Releases

Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results
05/03/18
Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May
05/01/18
Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call
04/26/18
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia
04/06/18
Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference
03/06/18
Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
02/28/18
University of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia Surgery
02/27/18
Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call
02/22/18
Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference
02/16/18
Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
02/15/18
Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
02/14/18
FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
02/12/18
WellStar Health System and Pacira Pharmaceuticals Announce Partnership to Minimize Opioid Use and Standardize Outcomes Across Surgical Procedures
01/08/18
Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million
01/04/18
Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
01/03/18